The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 1,301–1,400 of 1,810
Gherbon, A., Frandeș, M., Toderescu, C. D., Dîrpeş, D., Timar, R. Z., Nicula, M., Dascau, C., Daniluc, R., & Timar, B. (2025) · Medicina · doi:10.3390/medicina61071190 · Cited by 1
“The number of GD cases is expected to rise due to the increasing prevalence of obesity [4].”
Xie, C., Zheng, Q., Jiang, X., Liao, Y., Gao, X., Yu, Z., Li, J., & Liu, R. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1449000 · Cited by 1
Özkan, M. A., Dayanan, R., Bulan, D. D., Özkan, H. D., Aktemur, G., Karabay, G., Çakır, B. T., Şeyhanlı, Z., Yıldırım, A. A., Akın, F., et al. (2026) · The European Research Journal · doi:10.18621/eurj.1854589 · Cited by 1
Study of altered gut microbial dynamics and their association with gestational diabetes mellitus
Srivastava, A., Prabhakar, M. R., Mohanty, A., & Meena, S. S. (2023) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-022-00156-x · Cited by 1
“Alterations in gut microbial composition and metabolic changes occur simultaneously during normal pregnancy, resulting in higher production of endogenous glucose and lower insulin sensitivity by late pregnancy [31, 33].”
Yang, Y., & Yang, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1574480 · Cited by 1
“Effective clinical management requires deep understanding of the pathophysiologic cascade from intrauterine diabetic exposure to childhood metabolic dysfunction (3, 9).”
Gestasyonel Diyabetli Gebelerde Prenatal Bağlanma Düzeyi ve Doğuma Karşı Tutumun İncelenmesi
SÖĞÜT, Ö., & İnkaya, B. V. (2021) · Sağlık Akademisi Kastamonu · doi:10.25279/sak.750653 · Cited by 1
Anderson, N., Kimlin, K. R., O’Rourke, J. L., Reid, N., Callaway, L. K., Beswick, R., & Liddle, K. (2026) · Pediatric Research · doi:10.1038/s41390-026-04846-3 · Cited by 1
Manni, A., & Quarde, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-49872-6_4 · Cited by 1
Microfluidic and Organ-on-a-chip-based Technologies for Diabetes Therapy and Research
Morisseau, L., Messelmani, T., Essaouiba, A., Sakai, Y., Goff, A. L., Legallais, C., Leclerc, É., & Jellali, R. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165498-00188 · Cited by 2
Prediction of Diabetes in Middle-Aged Adults: A Machine Learning Approach
Addo, G., Yeboah, B. A., Obuobi, M., Doh-Nani, R., Mohammed, S., & Amakye, D. K. (2024) · Journal of Diabetology · doi:10.4103/jod.jod_103_24 · Cited by 2
Prasai, M., Lomré, M., Jelloul, E., Kleynen, P., Veltri, F., Sitoris, G., Grabczan, L., Rozenberg, S., & Poppe, K. G. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0339 · Cited by 2
“…pathway is through a common in fl ammatory pathway involving factors such as interleukin-6 (IL-6), IL-12, IL-10 and tumor necrosis factor that were shown to be signi fi cantly higher in women with autoimmune hypothyroidism (15, 16, 17) and euthyroid TAI+ women (16) compared to TAI (cid:1) controls.”
Roy, T., Das, A., Chatterjee, N., Saha, S. P., Prasad, R., Madan, T., Yasmin, H., & Kishore, U. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1731251 · Cited by 2
Jiang, J., Wei, S., Chen, M., Tan, Y., Yang, Z., Yang, G., Feng, W., Han, Z., Wei, X., & Luo, X. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3292324/v1 · Cited by 1
Hu, L., Liu, H., Liang, F., et al. (2025) · Medicine · doi:10.1097/md.0000000000043752 · Cited by 1
“[5] Despite advances in diagnosis and treatment, key aspects of GDM pathogenesis remain poorly understood.”
The Role of Afamin in Gestational Diabetes Mellitus: From Placental Dysfunction to Prediction
Murugesan, A., Mohanakrishnan, V. V., Karthiga Prabhu, J., Renuka, P., & Sivakumar, R. (2025) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-2676 · Cited by 1
Kawaguchi, C., Ishikuro, M., Saito, R., Murakami, K., Noda, A., Shinoda, G., Aizawa, M., Ohseto, H., Iwama, N., Orui, M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae825 · Cited by 2
Zavalza-Gómez, A. B., Pérez‐Hernández, S. C., Arrazola‐Fregozo, A. G., Espinel‐Bermúdez, M. C., Grover‐Páez, F., González, S. P., Ramos-Zavala, M. G., Cardona-Muñóz, E. G., Cardona‐Müller, D., & Hernández‐González, S. O. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15517 · Cited by 2
“The complications of GDM in the long term include diabetes and cardiovascular disease in the mothers, and obesity and diabetes in descendants.(14)”
BackgroundBadmus, O. O., Wahba, S., Arthur, G., Parrow, L. D., Montgomery, B., Cucolicchio, I. G., McGowan, K., & Taylor, E. B. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00871.2025 · Cited by 1
Li, M., Li, L., Liu, X., Yang, T., Gao, J., Wu, A., Hua, Z., & Wang, L. (2024) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2024.01066 · Cited by 1
Lee, C. Y. C., Sim, I. Y., Low, C. E., Tan, T. Y. Z., Aziz, A. F. L. A., Huang, Z., Tey, J. C. S., & Lee, A. R. Y. B. (2025) · Cancers · doi:10.3390/cancers17243924 · Cited by 4
“In normal pregnancy, insulin sensitivity fluctuates, with higher sensitivity during early pregnancy and decreased sensitivity during late pregnancy [57].”
InfluentialYilmaz, M., Aksin, Ş., Bozbay, N., Balsak, D., Aboalhasan, Y., Kurnuç, F. Z., Seyhan, L., & Batmaz, I. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5111250 · Cited by 2
Tranidou, A., Apostolopoulou, A., Siargkas, A., Magriplis, E., Tsakiridis, I. G., Koutsouki, G., Chourdakis, M., & Dagklis, T. (2025) · Nutrients · doi:10.3390/nu17203256 · Cited by 1
“GDM develops when the mother’s pancreas cannot produce enough insulin to overcome the natural insulin resistance that occurs during pregnancy, a state induced by placental hormones to ensure glucose supply to the fetus [4].”
Impact of Self-Management Clustered Care on Psychological and Birth Outcomes in Gestational Diabetes
Tang, S., Wang, S., Wu, J., Hu, S., Lü, T., Zhu, M., Li, J., & Xue, F. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s504365 · Cited by 3
“17 Pregnant women with GDM are hyperglycaemic, which leads to an increased risk of comorbidities such as gestational hypertension and preeclampsia.”
Bourgan, L. M., Pavy, K. A., Sumandea, F., Parise, C. A., Hankins, A. I., & Vyas, A. K. (2024) · doi:10.22541/au.172494984.45788894/v1
Ni, N., Li, L., Xiao, M., & Yu, F. (2024) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-06302-8 · Cited by 1
“During pregnancy, hormones produced by placenta, including human placental lactogen, estrogen and cortisol, may block insulin, resulting in insulin resistance [1–3].”
BackgroundНиколаевна, С. О., Putilova, N. V., & Tretyakova, T. B. (2025) · Russian Journal of Human Reproduction · doi:10.17116/repro202531051103
Liu, S., Feng, J., Ding, Y., & Liang, W. (2026) · Placenta · doi:10.1016/j.placenta.2026.08.339
Pathological mechanisms of gestational diabetes mellitus development
Salivon, H. (2025) · InterConf · doi:10.51582/interconf.19-20.10.2025.015
Furukawa, S., Kanamoto, A., Toyama, Y., Takeshita, K., Hashimoto, T., Miyake, T., & Tsuriya, D. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70393
Sulaiman, R. A., Alqasir, I., Alqasabi, D., Altassan, R., Tulbah, M., Alnemer, M., & Al‐Owain, M. (2026) · JIMD Reports · doi:10.1002/jmd2.70116
“Diagnosis is made when any glucose value meets or crosses the specified thresholds: fasting ≥ 5.1 mmol/L, 1-h ≥ 10.0 mmol/L, or 2-h ≥ 8.5 mmol/L [9, 10].”
InfluentialFilho, P. R. M., de Abreu, A. V. N., Coelho, E. C. S., & Pujadas, D. C. (2025) · Journal Archives of Health · doi:10.46919/archv6n1-006
Wu, H., Jin, Y., Pan, Q., Cheng, F., & Yue, C. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70139
“GDM affects about 14% of pregnancies globally, with long-term health consequences and a deficiency of widely accepted treatment strategies [10].”
The impact of Helicobacter pylori infection on Pregnancy: A narrative review
Besnier, M., Joseph, J.-Y., Laurandeau, A., Burucoa, C., Pichon, M., Frèche, B., & Poupin, É. (2026) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2026.115279 · Cited by 1
Increased Insulin Resistance in Roma Pregnancies
Pagkaki, C., Christou, O., Oikonomopoulou, D., Siateli, Z., Kalantaridou, S., Zoumakis, E., Πετράκος, Γ., & Halvatsiotis, P. (2025) · Diabetology · doi:10.3390/diabetology6100103
徐, 小. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123627
Association of maternal serum total homocysteine level with gestational diabetes mellitus
Haider, C., Islam, M. M., Fatema, M. M., Nesa, M. K., Khan, F. F., Ripa, H. J., Ahmed, N., & Eva, N. J. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20254288
Jin, B., Hu, M., Chen, J., & Yu, L. (2023) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v22i5.4
“A previous study using a genome-wide association approach revealed an association between COLEC12 and diabetic retinopathy in patients with T2D [15].”
BackgroundResultMining transcriptomic data for gestational diabetes mellitus: What public datasets reveal
Xie, L., Li, S., Zou, Y., Qin, D., Sun, J., Xiao, Y.-X., Li, T., Hao, Y., & Li, B. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i4.115275
Liu, J., He, T., Wang, Z., Sun, L., & Cheng, J. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08836-5 · Cited by 1
“Adverse pregnancy outcomes Included macrosomia, shoulder dystocia, fetal distress, postpartum hemorrhage, and other GDM-related outcomes [2, 3, 22].”
Engagement with gestational diabetes self-management: a qualitative study from the UK
Moore, A. P., Astbury, N. M., Poduval, S., & Ross, J. (2026) · BMJ Public Health · doi:10.1136/bmjph-2025-003909 · Cited by 1
Gestational diabetes mellitus and hypothyroidism: two sides of the same coin
Leffad, M. L., Startseva, N. M., Semyatov, S. M., Сергеевич, А. А., & Ивановна, С. М. (2023) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2023-8-2-120-128 · Cited by 1
Wang, F., Wu, J., Li, H., Gao, S., Zheng, Z., Wang, Z. H., & Gao, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1780579
“GDM results from an inadequate compensatory insulin secretion in the context of pregnancy-induced physiological insulin resistance (3, 4).”
Mao, J., Gan, Y., Tan, X., He, Y., Jing, Q., & Shi, Q. W. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s500632
“8 Recent research 9 has discovered that chronic inflammation is also involved in GDM pathogenesis.”
Li, L., Li, L., Shao, Y., Du, R., Shi, X., & Bai, Y. (2023) · Figshare · doi:10.6084/m9.figshare.23606864
Sun, J. F., Chen, Y., Chen, J., Zhao, T., Dong, H., Wang, H., Nan, Z., & Dai, B. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1833116
Haider, A., Mahdawi, E. N., Nasef, M., Shatla, E., & Nair, A. (2023) · Journal of Medical and Health Studies · doi:10.32996/jmhs.2023.4.5.8
“It has been proposed that increased placental sizes seen between 24 to 28 weeks of gestation can indicate a potential diagnosis of GDM (12).”
BackgroundMihiret, G. T., Wondmu, K. S., Baye, F., Minale, M., Yechale, M., Melesse, M. F., Melesse, Y. D., Haimanot, A. B., Adebabay, A. A., & Amha, H. (2026) · Obstetrics and Gynecology International · doi:10.1155/ogi/1739878
Maternal Cardiac Function in Pregnancies with Metabolic Disorders
Patel, D., & Savvidou, M. D. (2024) · European Cardiology Review · doi:10.15420/ecr.2023.28 · Cited by 2
“13 The National Institute of Health and Care Excellence (NICE) guidelines for diagnosing GDM include a fasting plasma glucose concentration ≥5.6 mmol/l and/or a 2-hour plasma glucose level ≥7.8 mmol/l. 58 Although the exact pathophysiology of GDM is uncertain, obesity, autoimmunity and genetic…”
BackgroundInfluentialEditorial: Recent advances in gestational diabetes: diagnosis, treatment and prevention
Punnose, J., Göbl, C. S., Glastras, S. J., & Tura, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1773541 · Cited by 1
(2020) · Journal of Gynecology & Reproductive Medicine · doi:10.33140/jgrm.04.02.03
Brain responses to food cue viewing in pregnant women with and without gestational diabetes mellitus
Montemayor, M. T., Lesniara-Stachon, A., Quansah, D. Y., Schenk, S., Heni, M., Kullmann, S., Toepel, U., Murray, M. M., Retsa, C., & Puder, J. J. (2026) · Communications Medicine · doi:10.1038/s43856-026-01792-3
“GDM is the most common metabolic complication in pregnancy, affecting approximately 16% of pregnant women worldwide 8 and is linked to substantial perinatal morbidity 9 .”
No effect of fetal sex on maternal insulin resistance: A cross‑sectional study
Hamdan, H. Z., Ahmed, S. F., Eltayeb, M. M., Rayis, D. A., & Adam, I. (2024) · World Academy of Sciences Journal · doi:10.3892/wasj.2024.297 · Cited by 2
“In some cases, this IR escalates and may precipitate gestational diabetes (2).”
Andonotopo, W., Bachnas, M. A., Prabowo, W., Yuliantara, E. E., Pramono, M. B. A., Dewantiningrum, J., Lukas, E., Sanjaya, I. N. H., Wiradnyana, A. A. G. P., Kusuma, A. A. N. J., et al. (2026) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_27_25
González-Saitz, A., & Kaser, S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1874930
“It is primarily characterized by progressive, hormonally mediated insulin resistance, which exceeds the compensatory secretory capacity of pancreatic beta-cells and leads to elevated blood glucose levels (2, 3).”
Gestational Diabetes Is Associated With Abnormalities in Glucose Excursion in Early Pregnancy
Al-Maraghi, S., Alzneika, S., Al-Ali, D., Al-Haddad, F., Hassan, A. M., Al-Thani, S. N., Al-Khalaf, N., Cyprian, F. S., Bougmiza, M. I., Nadeem, B., et al. (2025) · International Journal of Endocrinology · doi:10.1155/ije/9922593
Li, R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03404-0
“These exosomes can impact the way other cells work, which could contribute to the illness’s progression (Plows et al. 2018).”
RetractedSudana, I. N. G., Windarwati, W., & Mulyono, B. E. (2021) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v27i3.1697
Rossenrode, E., van Tonder, A., Lohse, I., Masetla, F. M., Adam, S., Oberholzer, H. M., & van Rooy, M.-J. (2026) · Ultrastructural Pathology · doi:10.1080/01913123.2026.2706777
Pszczolkowski, V. L., Youn, Y.-J., Her, T. K., & Alejandro, E. U. (2026) · Journal of Animal Science · doi:10.1093/jas/skag212 · Cited by 1
“…mechanisms underlying beta-cell dysfunction in GDM are complex and variable: beta-cells may malfunction at any point in the process, from glucose sensing, pro-insulin synthesis, or the exocytosis of insulin granules, as previously reviewed in the context of mouse pregnancy (Plows et al. 2018).”
Robiyanto, R., Veldkamp, N., van Puijenbroek, E., de Vos, S., Bos, J., Hak, E., & Schuiling‐Veninga, C. C. M. (2024) · Research Square · doi:10.21203/rs.3.rs-3915024/v1
Purc-Bandurko, K., Trojnar, K., Masiarz, A., Bandurko, A., Kimber-Trojnar, Ż., & Leszczyńska‐Gorzelak, B. (2026) · Biomolecules · doi:10.3390/biom16070998
“Glucose-stimulated insulin secretion and pancreatic β -cell mass are increased by hPL and prolactin [1–4], thereby supporting compensatory hyperinsulinemia during normal pregnancy.”
Zhou, C. D., Seah, R. L., & Papatheodorou, S. (2021) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2021.100094
Gebelikte Maternal Vücut Kitle İndeksi, Kilo Değişimi ve Perinatal Sonuçlar
Taşdemir, D., & Aşıcıoğlu, O. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4195
Peng, W., Zhulan, H., & Zhang, M. (2026) · International Journal of Endocrinology · doi:10.1155/ije/7371037
Khaleel, R., Malak, M. Z., Shehadeh, A., Zaben, K. J., Salameh, B. S., & Shawawreh, R. (2026) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70360
Identificación de factores que se asocian a alto riesgo de desarrollar diabetes gestacional
Sánchez, V. S., Cuenod, J. S. Á., González-Martín, J. M., Sala, L. M., Archilla, E., Merino, L. M., Delgado, T. B., Zrihen, Y. E., Martínez, A. M., & Hernández, J. Á. G. (2022) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2022.100774 · Cited by 3
Aspectos nutricionais no manejo do Diabetes mellitus gestacional
Raimundo, Y. R., Alcántara, G. G., & Garcia, P. P. C. (2023) · Research Society and Development · doi:10.33448/rsd-v12i6.42173 · Cited by 1
曾, 无. (2026) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2026.51054
Dhande, P., Dwidmuthe, K. S., & Bhalerao, A. V. (2026) · Cureus · doi:10.7759/cureus.115200
“GDM develops when maternal pancreatic ß-cells fail to secrete sufficient insulin to compensate for this heightened resistance, resulting in hyperglycaemia [8].”
Barbe, A. (2020) · theses.fr (ABES) · doi:10.70675/a1929a18zc99dz4f74zb8f8z614bf9e123e9
Tiwary, V., Muralidharan, M., Ramesh, R., & Pegu, B. (2026) · Cureus · doi:10.7759/cureus.106164
“As pregnancy progresses, insulin demand rises, and the combination of pancreatic β -cell insufficiency may lead to impaired glucose tolerance and ultimately to GDM [4].”
A INFLUÊNCIA DA ALIMENTAÇÃO BALANCEADA NA FERTILIDADE FEMININA
Alencar, J. V. A., Bertholucci, J. P., Amorim, L. C., Santana, A. J. P., Tiago, G. B., & de Aquino, É. C. (2023) · doi:10.56161/sci.ed.20230900c1
Bhushan, R., Rani, A., Trivedi, R., Gupta, D. K., Tripathi, A., Kumar, A., V, Rawat, S. G., & Dubey, P. K. (2023) · Research Square · doi:10.21203/rs.3.rs-2585404/v1
Li, X., Yu, H., Yu, K., Huang, Z., & Deng, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-92367-0
“This may be related to mechanisms of active fat metabolism in female adipocytes, which can impact insulin resistance and metabolic health, potentially heightening prediabetes risk in women with higher PBF 30–32 .”
Zeng, S., Wang, H., Yang, W., et al. (2026) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70263
“…biological heterogeneity, including differences in sample sources (maternal circulation vs. placental/fetal tissues), disease severity, gestational age at assessment, and post-transcriptional regulatory mechanisms (e.g., microRNA- 155-mediated suppression, protein stability modifications) [18, 19].”
Agarwal, P., Thakur, N., & Agrawal, S. (2026) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20260562
COMPLICAÇÕES FETAIS OCASIONADAS PELA DIABETES MELITUS GESTACIONAL: UMA REVISÃO DE LITERATURA
Bezerra, W. D. O., Silva, F. J. D. M., Resende, I. L., do Nascimento, M. F. A., Alves, J. S., da Costa, S. P., Lima, R. S., Capingana, I. N. C., Silva, F. M. D. S. F., Soares, R. P. G., et al. (2024) · Revista Foco · doi:10.54751/revistafoco.v17n5-162 · Cited by 1
Escapita, A. C., Glatter, A., Siegel, E. R., Johnson, T. L., Eswaran, H., & Escalona‐Vargas, D. (2025) · Early Human Development · doi:10.1016/j.earlhumdev.2025.106461
Cui, L., Li, Z., Chen, T., Li, Z., Guo, Y., Li, J., Yang, X., Zhang, L., Li, X., Hua, L., et al. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01420-7 · Cited by 1
DIABETES MELLITUS GESTACIONAL: RASTREAMENTO, DIAGNÓSTICO, TRATAMENTO E REPERCUSSÕES MATERNO-FETAIS
Campos, K. K. L. (2026) · RECIMA21 - Revista Científica Multidisciplinar · doi:10.47820/recima21.v7i9.8951
Vidyashri, R., Nirmala, M., Beaulah Mercy Mary, T., Vanaja, P., Usha, H. T., Roslin, A., Umar, M., Sharmila, P., Subrahmanyam, N., Suhashini, et al. (2026) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20262307
Maternal Immune-Mediated Conditions and ADHD Risk in Offspring
(2025) · doi:10.21203/rs.3.rs-5594521/v1
“GDM, emerging during pregnancy 82 , shares features like insulin resistance with T2D and lacks T1D’s autoimmune aspect 33 .”
Gestational Diabetes Mellitus: Prevalence, Management and Prevention
Łakoma, A., Choiński, M., Marzec, W. Z., Wasiewicz-Ciach, P., Marszałek, A., Wydra-Rojek, A., Kutyła, K., Mokot, W. J., Marzec, M. T., & Kuczyński, P. (2024) · Quality in Sport · doi:10.12775/qs.2024.21.54076 · Cited by 1
Zhang, Y., Li, C., Lin, R., Feng, Y., Zhang, F., & Zhang, G. (2022) · PubMed Central
Amelia, R., Arista, D. M., Fitriani, D., Khotimah, H., Ratnaningrum, S. D., Irwanto, Y., & Nurseta, T. (2025) · AIP conference proceedings · doi:10.1063/5.0237873
Immune dysregulation linking pre-pregnancy obesity to gestational diabetes mellitus
Skarstad, H. M. S., Sujan, M. A. J., Moholdt, T. T., & Zulu, M. Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1940789
“These pre-existing immune abnormalities reduce metabolic fl exibility and impair the maternal adaptations required to maintain glucose homeostasis, thereby increasing susceptibility to GDM (11, 65).”
Yu, H., Yu, X., Liu, Y., Alarfaj, A. A., & Hirad, A. H. (2026) · 3 Biotech · doi:10.1007/s13205-026-04785-0 · Cited by 1
“Several factors contribute to the development of GDM, including genetic predisposition, adipokines, placental hormones, oxidative stress, and inflammatory cytokines (Vrach - nis et al. 2012; Plows et al. 2018; McIntyre et al. 2019).”
The Dual Faces of Gestational Diabetes Mellitus: Maternal and Placental Origins
Avagliano, L., Parodi, C., Ottanelli, S., Mecacci, F., Massa, V., & Bulfamante, G. (2026) · American Journal of Perinatology · doi:10.1055/a-2884-8925 · Cited by 1
Papel del ejercicio físico en la prevención de la diabetes gestacional
de Rojas, S. A. P., & Prieto, A. G. (2023) · Conocimiento Enfermero · doi:10.60108/ce.266
Li, R., Sun, Y., Liang, Q., He, X., Nie, L., Huang, J. H., & Yu, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1665813
COURSE AND OUTCOME OF PREGNANCIES COMP
Kocijancic, D., Bogicevic, I., Brezic, N., Akšam, S. S., & Dotlić, J. (2022) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/8328021
Metformin and Placental Ferroptosis in Gestational Diabetes: A Mechanistic Study
Lin, Q., Qin, X., Shen, M., Xia, D., Cao, X., She, G., Wang, H., & Zhou, W. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/2226729
“Its pathogenesis is influenced by multiple factors, including oxidative stress imbalance, chronic inflammation, dysregulated lipid metabolism, IR, and placental dysfunction [2].”
Lamadi, S., Prastiwi, F. D., Raras, T. Y. M., Khotimah, H., & Wıyasa, I. W. A. (2023) · Medical Laboratory Technology Journal · doi:10.31964/mltj.v9i2.537
“Manifestations of cell dysfunction due to insulin resistance during pregnancy trigger a progressive risk of type 2 diabetes mellitus after pregnancy ends (Plows et al., 2018).”
BackgroundMota, L. P., Filho, P. S. D. P. S., & Nunes, J. K. O. (2023) · doi:10.56161/sci.ed.20230900
Jung, Y. W., Lee, M., Ko, Y. B., Song, S. Y., Yoo, H. J., Kang, Y. E., Kim, O. S., Kang, B. H., & Kim, H. J. (2025) · Research Square · doi:10.21203/rs.3.rs-6016485/v1
The Relationship Between Race and Gestational Diabetes Mellitus
Saji, S., Shah, S., Stumbar, S. E., de la Vega, P. R., & Lozano, J. M. (2025) · Cureus · doi:10.7759/cureus.92941
“Gestational diabetes mellitus (GDM) can have long-term negative health consequences, including increased risk for both the mother and child to develop type 2 diabetes mellitus (T2DM) later in life [2].”
Wang, X., Zhang, J. S., Zhan, S., & Xu, X. (2026) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-026-08353-y · Cited by 1
“GDM arises from a complex interplay of insulin resistance, β -cell dysfunction, placental hormone-mediated glucose metabolism disorders, and gut microbiota alterations [2, 19, 31], with placental immune microenvironment also implicated [32].”
Borba, C. D. P. C., Aranha, A. G. T., Rodrigues, J. C., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n12-074
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.